Beyond the Laboratory: An Empirical Analysis of Human Research Ethics in the Digital and Technological Age
What if the next device to measure your child’s attention isn’t a test, but a headband? Who would you ask about the data it collects? Would anyone have to ask you first?
These are not science-fiction questions. Brain-sensing wearables are already sold for focus, sleep, and learning. Money is pouring into the field. And the rules that protect people from harm have not kept pace. This post walks through what the money looks like, what the United Nations has warned about, what the Belmont Report asks of researchers, and what governance we still need, especially for children and people with disabilities.
The harm has left the lab
How often do you think about where harm can happen in the digital age? It no longer sits only in the clinic or the laboratory. It can arrive through information, algorithms, and systems that affect individuals and whole communities. Technology has transformed society since the 1990s, yet ethical frameworks have not always moved at the same speed. The public often lacks reliable education about what these technologies can and cannot do, and misconceptions fed by science fiction and misinformation fill the gap. Ethical frameworks, laws, and public policy have to stay at the center of both public understanding and technological development. Here is the uncomfortable part: when a technology is poorly disclosed or hard to understand, can anyone truly consent to it? The UN's Human Rights Council Advisory Committee asks the same thing. It finds it difficult to imagine how people could give informed consent to neurotechnology devices, especially consumer ones, when their long-term effects remain largely unknown (A/HRC/57/61, para. 30).
What the Belmont Report asks of researchers
Who is supposed to protect research participants? Since 1979, the Belmont Report has offered the foundation, built on three principles: Respect for Persons: people are autonomous, and those with diminished capacity, such as children, people with disabilities, and prisoners, are owed extra protection. Beneficence: minimize harm and maximize benefit. Justice: the burdens and benefits of research should be shared fairly, not loaded onto the vulnerable. Most high-risk human research must be reviewed by an Institutional Review Board (IRB) before it starts. If a researcher treats a group as the subject of a study, consent, disclosure, and participant protections should be reviewed and approved before observation, inference, and data collection begin. But do all researchers call their work human subjects research? Do all studies get oversight? Not necessarily. Consumer products, commercial analytics, and "wellness" tools can sit outside traditional review while collecting some of the most sensitive data a person can produce.
Follow the money
How big is the business of neurotechnology? One industry analyst, Neurotech Reports, put worldwide neurotechnology product sales at about: Year Estimated global market (devices) 2014 $6.4 billion 2016 $7.6 billion 2018 $8.4 billion2026roughly $17.8 to $19.8 billion The 2026 range comes from several market-research firms (estimates cited include about $17.8 billion, $19.2 billion, and $19.8 billion), and the exact figure depends on what each report counts. Narrower slices are much smaller: brain-computer interfaces alone are estimated at only a few billion dollars, and estimates vary widely. Treat every number here as an analyst estimate, not an official statistic, and not a measure of national output. Still, the direction is clear: on these estimates, the market roughly doubled between 2018 and 2026. The UN Advisory Committee points to an even sharper curve in investment. Since several countries launched large national brain initiatives from 2013, public and private funding for neurotechnology rose from about $331 million to about $7.3 billion in barely a decade (A/HRC/57/61, para. 12). The sector is also shifting toward private companies making products for direct sale to consumers. So, what about the data itself? Is brain data the world's most valuable asset? Nobody can honestly say. No reliable price tag exists for it, and that is part of the problem. What the UN report does say is that data collected by neurotechnology devices, medical and non-medical, is likely to see its commercial value grow dramatically (para. 24), that data can be sold to third parties without users knowing or agreeing, and that consumer neurotech companies are already collecting large amounts of personal data in the hope it will one day become decipherable (para. 25). If the data is becoming a commodity, who is the product?
Money moves faster than the rules
Who is paying for all this innovation, and who is paying for the guardrails? Governments fund neurotechnology and AI because they promise cures, jobs, and growth. In the United States, Congress set fiscal year 2026 funding for the National Institutes of Health at $47.2 billion, including $429 million for the BRAIN Initiative, a 33 percent jump over the year before. Federal AI research and development was expected to total roughly $3.3 billion in fiscal year 2025, not counting classified programs. Funding science is not the problem. The problem is what does not come attached. These are research budgets: they pay for discovery. They do not decide who may collect brain data, who may sell it, or how children and people with disabilities are shielded from misuse. What the law covers. As of this writing, the United States has no federal law written for neural data. Existing laws reach only the edges: HIPAA covers health information held by covered entities, COPPA covers some online data about children under 13, and the FTC can act against deceptive practices. A bill in Congress, the MIND Act of 2025, would direct the FTC to study how neural data is governed and where the gaps are under those laws. It had not passed in the most recent reporting available when this was written. States are filling the gap, unevenly. Colorado was first, in April 2024, followed by California, Montana, and Connecticut, whose law took effect on July 1, 2026. Their definitions differ: Connecticut covers only the central nervous system, California reaches the peripheral nervous system too, and analysts note that Colorado's applies only when the data is used to identify a person. In the first six weeks of 2026 alone, at least nine more bills were introduced in six states. So is your child's brain data protected? It depends on which state you live in. Companies are not waiting. In 2024, the Neuro rights Foundation reviewed the privacy policies of 30 consumer neurotechnology companies. It found that 29 appeared to have access to users' neural data without meaningful limits, and 20 reserved the right to share or sell it to third parties. Data does not stop at borders. Apps and cloud services can move brain data between countries, but protections do not travel with it. The UN report notes that users' control over their data is not equally strong from one country to another (para. 25), and that national responses are fragmented and insufficient (paras. 58 to 60). It also warns that large companies seeking profit are likely to exploit regulatory gaps, and that big technology firms will inevitably push more neurotechnology products to market (paras. 12 and 13). Where is your data stored, under whose rules, and who can see it? What should change. If public money helps build the tools, shouldn't public rules protect the people who use them? The UN report points toward safeguards that travel with the funding and the products: independent human-rights impact assessments (para. 74), binding standards and sanctions for companies (para. 73), and consent that is prior, free, and informed, never presumed (para. 80). Advocates add a federal neural data law that treats brain data as especially sensitive, stronger protection for children and people with disabilities, and safeguards for data that crosses borders.
What the United Nations has warned
In 2022, Human Rights Council resolution 51/3 asked its Advisory Committee to study neurotechnology and human rights. The result, report A/HRC/57/61 (August 2024), makes several points worth every reader's attention: The sector is growing fast and is barely regulated. Medical neurotechnology generally sits inside established frameworks. The booming consumer sector largely does not (paras. 12 to 13). Many consumer products are unproven. For most commercial products, effectiveness is neither established nor supported by scientific evidence, and studies of side effects and long-term effects are lacking (para. 10). Neuro data is unusually sensitive. It can reveal personality traits, cognitive performance, and states such as emotions, intentions, and beliefs (para. 24). Tracking at work and school is a live concern. Neurotechnology used for surveillance in workplaces, educational settings, and private life could cause further harm to privacy (para. 25). Could your employer, your school, or an app one day infer your focus, stress, or mood from your brain signals? The report says the risk is real enough that rules are needed now.
Neuromarketing: when surveillance meets the sales funnel
Have you ever wondered how an ad seems to know exactly what will hold your attention? Neuromarketing studies the brain mechanisms behind consumer behavior and decisions, and tailors messages to particular neurotypes. The UN report warns that these strategies have already been shown to shape opinion formation and influence decision-making. They let private actors, such as marketing engineers and political campaigners, steer behavior to an unprecedented degree. And because the technologies are sold widely for personal use, including during sleep, the influence can happen without the person knowing or consenting (para. 21)."Neurogaming" raises a related concern. Devices can encourage compulsive or addictive behavior, and immersive systems that adjust to detected brain data can be turned toward changing behavior (para. 21). Who is watching the watchers? Right now, in most places, no one in particular.
Children and people with disabilities
Why are children singled out? Because their brains are still developing. The report notes that children and adolescents may be especially vulnerable to the negative effects of neurotechnology, which may shape identity formation, affect autonomy, and create dependency. Research has not yet determined how these technologies affect brain development or identity formation in children, and detailed studies of the effects on children's rights do not exist (para. 40). Then comes the passage that deserves the most attention. The report notes that brain-computer interfaces are expected to spread into video games in coming years, exposing young users to unforeseen effects and lasting mental or psychological harm. It adds that, using modern surveillance tools, it is possible to obtain information about a child's mental state, make predictions about their health, and influence their behavior. Neurotechnologies can also exploit or influence children's cognitive and sensory experiences, thoughts, and emotions, or harm their mental and physical integrity. And neuromarketing, which by nature puts commercial interests ahead of the child's interest, can be extremely manipulative (para. 41). The report is clear about what follows: the best interests of the child must come first, which calls for regulating neurotechnology in games, advertising, and marketing aimed at children. It also notes that parents may be misled into believing a product boosts their child's abilities and impose it on them (para. 42). People with disabilities face a different risk. They are disproportionately targeted by medical and scientific research and experimentation, and neurotechnology is often developed without clear human-rights guidelines or real monitoring. That exposes them to disproportionate risk of physical or psychological harm (para. 38). At the same time, they have a right to safe, secure, rights-respecting neurotechnology and to assistive technology that makes life more independent. The report is firm that no one with a disability can be forced to use neurotechnology, and any experimentation without free and informed consent is prohibited (para. 39). Can we celebrate a device that restores movement while asking who tested it, who consented, and who profits? We have to do both.
An honest note about what the technology can and cannot do
Does any of this mean someone is reading your thoughts right now? The UN report itself is careful here. It says most neurotechnologies are still experimental and cannot decipher thoughts accurately, so it is not yet possible to read or steer what someone thinks (para. 7). The near-term danger is not mind-reading. It is data, inference, and commercialization: collecting brain and body signals, using AI to draw conclusions about mental states, and using those conclusions to profile, predict, and influence people.That honesty matters for another reason. Some people believe a hidden technology is affecting them and struggle to find anyone who will examine their concerns. What should happen to them? Two failures are possible: concerns dismissed without examination, and claims accepted without evidence. Good governance avoids both. It means a real medical and technical evaluation, honesty about what is and is not known, and accessible routes to remedy. The report itself notes that people harmed by neurotechnology may not be aware of the violation or have the information needed to exercise their rights (para. 72).
The governance we need now
What would protect children, people with disabilities, and everyone else? The UN report and the Council's 2025 follow-up (resolution 58/6) point toward concrete steps: Binding rules for companies. Regulation, accountability systems, and sanctions for firms that develop or sell neurotechnology, along with independent human-rights impact assessments built into their business models (paras. 73 to 74). Real consent. Consent to any neurological intervention must be prior, free, informed, and never presumed, with special protection for people with mental health conditions and disabilities (para. 80). Child protection by design. National rules aligned with the Convention on the Rights of the Child, with the best interests of the child as the guide (para. 80). Nothing about us without us. Consultation with disabled people, including children, through the organizations that represent them (para. 80). Stronger data protection. Recognition that brain data needs protections tailored to its sensitivity, and stronger consent requirements to stop it being collected without permission (para. 26). Global guidelines. Resolution 58/6 asks the Advisory Committee to draft recommended guidelines for applying human rights to neurotechnology, to be presented to the Council at its sixty-fourth session. Open public debate. Decisions about development and deployment should come after open public debate, with continuing democratic oversight (para. 75). Some countries have begun. Chile wrote mental privacy and psychological integrity into its Constitution, and Brazil has strengthened protection for mental data. But the report describes most national responses as fragmented and insufficient (paras. 58 to 60).
Questions to ask before you or your child use any neurotech product
Does a regulator review the claims this product makes, or is it sold as "wellness"?Who tested whether it works, and were they independent of the company?What brain or body data does it record, where is it stored, and who can buy or access it?Can I delete my data and still use the product?If this is a research study, did an ethics board review it, and was consent explained in plain language?If it is for a child, who benefits commercially, and how do we know it serves the child's interests?
Your move
What will you do with what you have just read? Read the report. Ask your child's school, your employer, and the companies behind the gadgets you use the questions above. Support laws that treat brain data as especially sensitive. And share this post with someone who has never heard the word neurorights.The technology will keep advancing. Whether it advances with consent, transparency, and respect for human dignity is up to us.
Sources
Human Rights Council Advisory Committee, Impact, opportunities and challenges of neurotechnology with regard to the promotion and protection of all human rights, A/HRC/57/61 (8 August 2024). Paragraph numbers above refer to this report.Human Rights Council resolution 51/3, Neurotechnology and human rights (6 October 2022).Human Rights Council resolution 58/6, Neurotechnology and human rights (2 April 2025).National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, The Belmont Report (1979).Market figures: Neurotech Reports (2014, 2016, and 2018 market studies); 2026 estimates from Mordor Intelligence, Fortune Business Insights, and The Business Research Company, as reported on their public pages.U.S. funding: Consolidated Appropriations Act, 2026 (signed February 3, 2026), NIH at $47.2 billion and the BRAIN Initiative at $429 million, as reported by the Society for Neuroscience and The Transmitter; NITRD and NAIIO budget supplements for federal AI R&D figures.Neurorights Foundation, Safeguarding Brain Data: Assessing the Privacy Practices of Consumer Neurotechnology Companies (April 2024).U.S. neural data laws and proposals: Colorado H.B. 1058 (2024), California SB 1223 (2024), Montana SB 163 (2025), Connecticut SB 1295 (2025), and the MIND Act of 2025, as analyzed by the Future of Privacy Forum and law-firm summaries.
Discover more from Advocacy For Neuro Rights inc.
Subscribe to get the latest posts sent to your email.